{"data":[{"accessionNo":"0000902664-26-003500","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Sessa Capital IM, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":1500000,"percentOfClass":8.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0000902664-26-003500","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"John Petry","reportingCik":null,"personType":"HC,IN","sharesOwned":1500000,"percentOfClass":8.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0000080255-26-000590","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002093101","issuerName":"ATRIUM THERAPEUTICS INC","ticker":"RNA","cusip":"04965N104","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"T. Rowe Price Associates, Inc.","reportingCik":null,"personType":"IA","sharesOwned":1472984,"percentOfClass":8.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0001231919-26-000917","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0001231919-26-000917","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0001231919-26-000917","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0001231919-26-000917","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0002012383-26-002192","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":1135757,"percentOfClass":6.6,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0001346824-26-000145","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":864102,"percentOfClass":5.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0001346824-26-000145","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":864102,"percentOfClass":5.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0001346824-26-000145","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":864102,"percentOfClass":5.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0001346824-26-000145","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":864102,"percentOfClass":5.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0002012383-26-001673","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002093101","issuerName":"Atrium Therapeutics, Inc.","ticker":"RNA","cusip":"04965N104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":892387,"percentOfClass":5.2,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/rna"},{"accessionNo":"0000080255-26-000316","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002093101","issuerName":"ATRIUM THERAPEUTICS INC","ticker":"RNA","cusip":"04965N104","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Associates, Inc.","reportingCik":null,"personType":"IA","sharesOwned":1553210,"percentOfClass":10,"filedAt":"2026-04-08","canonicalUrl":"https://xoomar.com/markets/stocks/rna"}],"updatedAt":"2026-11-03T16:42:23.675Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rna","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}